Results 261 to 270 of about 39,021 (326)

Prognostic significance of circulating tumor DNA in non-metastatic colorectal cancer. [PDF]

Discov Oncol
Li R, Wang S, Xu J, Zhao M, Zhang H, Yin Y, Han X, Liu B, Liu W.   +8 more
europepmc   +1 more source

Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial. [PDF]

JAMA Oncol
Zhang GQ, Meyerhardt JA, Shi Q, Twombly T, Pederson L, Ma C, Väyrynen JP, Zhao M, Takashima Y, Shergill A, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Tan B, O'Reilly EM, Giannakis M, Ogino S, Jurdi A, Sharma S, Aleshin A, Shields AF, Nowak JA.   +22 more
europepmc   +1 more source

Adaptive therapy for perioperative non-small cell lung cancer: strategies guided by dynamic minimal residual disease adjustment. [PDF]

Transl Oncol
Xie LJ, Fu LL, Liu SC, Bai CS, Xu BC, He XW, Lin HF, Zeng YC, Tang WJ.   +8 more
europepmc   +1 more source

68O Blood ctDNA vs tumor tissue screening for the detection of KRAS mutations in low-grade serous ovarian cancer

Els Van Nieuwenhuysen, Rachel N. Grisham, Isabelle Laure Ray-Coquard, Charles Anderson, A.R. Clamp, Christopher Seungkyu Lee, M.J. Rubio Pérez, Anna Priebe, N. Colombo, Lynne M. Knowles, Emilie Kalbacher, David S. Miller, Toon Van Gorp, Erika Hamilton, A. Santillan-Gomez, AR Thummala, Christopher Tweed, Sílvia Coma, Samantha Hidy, Susana Banerjee   +19 more
openalex   +2 more sources

Current Status and Future Challenges of Liquid Biopsy. [PDF]

Cells
Ohara S, Suda K.
europepmc   +1 more source

Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma [PDF]

Ibone Labiano, Ana E. Huerta, María Alsina, Hugo Arasanz, Natália Castro, Saioa Mendaza, Arturo Lecumberri, Iranzu González‐Borja, David Guerrero‐Setas, Ana Patiño‐García, Gorka Alkorta‐Aranburu, Irene Hernández-García, Virginia Arrazubi, Elena Mata, David Gómez, A. Viúdez, Ruth Vera   +16 more
openalex   +1 more source

Genetics of mCRPC tracked in ctDNA [PDF]

Nature Reviews Clinical Oncology, 2016
openaire   +1 more source

Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies. [PDF]

MedComm (2020)
Liu L, Liang W, Cao W, Wang H, Liang H, Huang L, Zhong D, Gao W, Deng Q, Zhang Y, Zeng X, Wang W, Huang J, Yang C, Peng G, Zheng X, Ma J, Du X, Cui L, Guan Y, Bai J, Xia X, Yi X, He J.   +23 more
europepmc   +1 more source

DNA lliure circulant: un nou concepte de marcador tumoral [PDF]

, 2018
Augé Fradera, JM., Carbonell Prat, M., Colomé Mallolas, C., de Ramon Amat, M., Filella Pla, X., Foj Capell, L., Granada Ybern, ML., Miró Cañís, S., Trapé Pujol, J.   +8 more
core   +1 more source

Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers. [PDF]

Adv Sci (Weinh)
Fei K, Zhao J, Xu J, Duan J, Li C, Xie W, Zhong J, Wang G, Xu Y, Sun B, Wan R, Bai H, Guo Q, Guo W, Cai S, Wang Z, Wang J.   +16 more
europepmc   +1 more source